Case number 1:18-cv-00262
Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 16, 2019 | 22 | Order (3) Docket Text: CONSENT JUDGMENT as to Breckenridge Pharmaceutical Inc., ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 5/14/19. Associated Cases: 1:16-cv-01001-LPS, 1:18-cv-00262-LPS, 1:19-cv-00071-LPS (ntl) |
| May 10, 2019 | 21 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT - Breckenridge Pharmaceutical, Inc. by Onyx Therapeutics, Inc.. (Jacobs, Karen) |
| Jul 18, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:16-cv-00988-LPS. (ntl) |
| Jul 18, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] STIPULATION and Order Regarding Consolidation filed by Onyx Therapeutics, Inc. Signed by Judge Leonard P. Stark on 7/17/18. (ntl) |
| Jul 16, 2018 | 20 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Consolidation by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Jul 11, 2018 | N/A | SO ORDERED (0) |
| Jul 10, 2018 | 19 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for Parties to Submit a Proposed Scheduling Order to July 17, 2018 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Jun 26, 2018 | N/A | Order (0) |
| Jun 18, 2018 | N/A | SO ORDERED (0) |
| Jun 15, 2018 | 17 | Answer to Counterclaim (12) Docket Text: ANSWER to [10] Answer to Amended Complaint, Counterclaim -- Answer to Counterclaims -- by Onyx Therapeutics, Inc..(Noreika, Maryellen) |
| Jun 13, 2018 | 16 | Stipulation (3) Docket Text: STIPULATION regarding infringement by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Jun 5, 2018 | 15 | Notice (Other) (2) Docket Text: NOTICE of Dismissal Without Prejudice of Counts XI-XVIII of its Counterclaims by Breckenridge Pharmaceutical, Inc. re [10] Answer to Amended Complaint, Counterclaim (Farnan, Kelly) |
| May 16, 2018 | N/A | SO ORDERED (0) |
| May 14, 2018 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff to answer, move, or otherwise respond to Breckenridge's counterclaims to June 15, 2018 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| May 9, 2018 | N/A | SO ORDERED (0) |
| May 1, 2018 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Onyx to Answer, Move or Otherwise Respond to Breckenridge's Counterclaim [DI 10] to May 16, 2018 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) |
| Apr 11, 2018 | 10 | Main Document (43) Docket Text: ANSWER to Amended Complaint, re: [8] Amended Complaint , COUNTERCLAIM against Onyx Therapeutics, Inc. by Breckenridge Pharmaceutical, Inc.. (Attachments: # (1) Exhibit 1 through 4)(Farnan, Kelly) |
| Apr 11, 2018 | 10 | Answer to Amended Complaint (43) |
| Apr 11, 2018 | 10 | Exhibit 1 through 4 (159) |
| Apr 11, 2018 | 11 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,232,818 B2; 7,491,704 B2; 8,129,346 B2; 8,207,297 B2; . (Farnan, Kelly) |
| Apr 11, 2018 | 12 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pensa Pharma, S.A. for Breckenridge Pharmaceutical, Inc. filed by Breckenridge Pharmaceutical, Inc.. (Farnan, Kelly) |
| Mar 9, 2018 | 8 | Amended Complaint (18) |
| Mar 9, 2018 | 8 | Amended Complaint* (1) |
| Mar 9, 2018 | 8 | Main Document (18) Docket Text: First AMENDED COMPLAINT against Breckenridge Pharmaceutical, Inc.- filed by Onyx Therapeutics, Inc.. (Attachments: # (1) Exhibit A - E)(Noreika, Maryellen) |
| Mar 9, 2018 | 8 | Exhibit A - E (184) |
| Mar 9, 2018 | 9 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,417,042 B2; 7,232,818 B2 - WITHDRAWN BY 3/9/2018 AMENDED COMPLAINT; 7,491,704 B2 - WITHDRAWN BY 3/9/2018 AMENDED COMPLAINT; 7,737,112 B2; 8,129,346 B2 - WITHDRAWN BY 3/9/2018 AMENDED COMPLAINT; 8,207,125 B2; 8,207,126 B2; 8,207,127 B2; 8,207,297 B2 - WITHDRAWN BY 3/9/2018 AMENDED COMPLAINT . (Noreika, Maryellen) |
| Mar 5, 2018 | 6 | Request for Waiver of Service (1) Docket Text: REQUEST FOR WAIVER of Service sent to Breckenridge Pharmaceutical, Inc. on 2/22/2018 by Onyx Therapeutics, Inc.. Waiver of Service due by 3/26/2018. (Noreika, Maryellen) |
| Mar 5, 2018 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Onyx Therapeutics, Inc.: For Breckenridge Pharmaceutical, Inc. waiver sent on 2/22/2018, answer due 4/23/2018. (Noreika, Maryellen) |
| Feb 21, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (nms) |
| Feb 15, 2018 | 1 | Complaint (26) |
| Feb 15, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Breckenridge Pharmaceutical, Inc. on 2/15/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (fms) |
| Feb 15, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc., Corporate Parent Onyx Pharmaceuticals, Inc. for Onyx Therapeutics, Inc. filed by Onyx Therapeutics, Inc. (fms) |
| Feb 15, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See patent report. (fms) |
| Feb 15, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/3/2018. Date of Expiration of Patent: See form.Thirty Month Stay Deadline: 7/3/2020. (fms) |
| Feb 15, 2018 | 1 | Main Document (26) Docket Text: COMPLAINT For Patent Infringement filed against Breckenridge Pharmaceutical, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2323767.) - filed by Onyx Therapeutics, Inc. (Attachments: # (1) Exhibits A-I, # (2) Civil Cover Sheet)(fms) |
| Feb 15, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (fms) |
| Feb 15, 2018 | 1 | Civil Cover Sheet (2) |
| Feb 15, 2018 | 1 | Exhibits A-I (343) |
| Feb 15, 2018 | 1 | Complaint* (1) |
